Zobrazeno 1 - 10
of 22
pro vyhledávání: '"T P, Gross"'
Autor:
Emilie T. E. Gross, Carlos D. Peinado, Yujin Jung, Semi Han, Beichen Liu, Endi K. Santosa, Jack D. Bui
Publikováno v:
OncoImmunology, Vol 8, Iss 1 (2019)
The cancer stem cell (CSC) paradigm posits that specific cells within a tumor, so-called CSC-like cells, have differing levels of tumorigenicity and chemoresistance. Original studies of CSCs identified them in human cancers and utilized mouse xenogra
Externí odkaz:
https://doaj.org/article/ff5eb7227af54b2bba20fe2376fdeb1c
Autor:
Emilie T. E. Gross, Semi Han, Prasantha Vemu, Carlos D. Peinado, Martin Marsala, Lesley G. Ellies, Jack D. Bui
Publikováno v:
OncoImmunology, Vol 6, Iss 2 (2017)
Evidence of cancer immunosurveillance and immunoediting processes has been primarily demonstrated in mouse models of chemically induced oncogenesis. Although these models are very tractable, they are characterized by high mutational loads that repres
Externí odkaz:
https://doaj.org/article/55a7f9224e48485a9f912db60aa83a38
Publikováno v:
Musculoskeletal Surgery
Abstract Recent advancements in arthroplasty surgical techniques and perioperative protocols have reduced the duration of hospitalization and length of recovery, allowing surgeons to perform joint replacement as an outpatient procedure. This study ai
Autor:
D W Lennox, T P Gross
Publikováno v:
The Journal of Bone & Joint Surgery. 74:1096-1101
Autor:
Kenneth G. Saag, D. Briggs, Mary Elkins Melton, T. P. Gross, Young Kim, Amy S. Mudano, Jeffrey R. Curtis, Juan Xi, Jeroan J. Allison, J. U. Cope, J. Bian
To better understand the risk of secondary vertebral compression fracture (VCF) following a vertebroplasty or kyphoplasty, we compared patients treated with those procedures to patients with a previous VCF. The risk of subsequent fracture was signifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d974cb27ca166f8e706e67b1d44e5ad
https://europepmc.org/articles/PMC4089886/
https://europepmc.org/articles/PMC4089886/
Autor:
G G, White, M D, Weick-Brady, S A, Goldman, T P, Gross, D L, Kennedy, B S, Lucas, K, Merritt, C, Naschinski
Publikováno v:
CRNA : the clinical forum for nurse anesthetists. 9(4)
Healthcare practitioners are the primary users of medical devices for direct patient care. As such, they are in the best position to recognize problems that result from the use of medical devices. The outcome of a device-related adverse event or prod
Autor:
T P, Gross, L G, Kessler
Publikováno v:
Studies in health technology and informatics. 28
This overview of medical device vigilance at the U.S. Food and Drug Administration (FDA) discusses the basic reporting regulation and program at FDA. The FDA program has grown to the point where we now receive over 100,000 reports per year. How FDA e
Publikováno v:
Public health reports (Washington, D.C. : 1974). 110(1)
Data on pacemaker implantation were obtained from the Medical Device Implant Supplement to the 1988 National Health Interview Survey, a nationally representative, population-based survey of 47,485 households (122,310 persons). The survey yielded an e
Autor:
T P, Gross, J J, Schlesselman
Publikováno v:
Obstetrics and gynecology. 83(3)
To determine the effect of oral contraceptive (OC) use on the cumulative incidence of epithelial ovarian cancer from ages 20-40, 20-50, and 20-55 years among four groups of women: positive family history, negative family history, parous, and nullipar
Autor:
T P, Gross, D W, Lennox
Publikováno v:
The Journal of bone and joint surgery. American volume. 74(7)